List of HCPCS codes for: Medical Services (M-codes)

HCPCS Code	Short Description	Long Description
M0001	Advancing cancer care mvp	Advancing cancer care mips value pathways
M0002	Opt care kidney hlth mvp	Optimal care for kidney health mips value pathways
M0003	Opt care episod neuro mvp	Optimal care for patients with episodic neurological conditions mips value pathways
M0004	Support care neur cond mvp	Supportive care for neurodegenerative conditions mips value pathways
M0005	Value in primary care mvp	Value in primary care mips value pathway
M0010	Eom meos payment	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
M0064	Visit for drug monitoring	Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders
M0075	Cellular therapy	Cellular therapy
M0076	Prolotherapy	Prolotherapy
M0100	Intragastric hypothermia	Intragastric hypothermia using gastric freezing
M0201	Pne flu hepb cov home admin	Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home
M0220	Tixagev and cilgav inj	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring
M0221	Tixagev and cilgav inj hm	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0222	Bebtelovimab injection	Intravenous injection, bebtelovimab, includes injection and post administration monitoring
M0223	Bebtelovimab injection home	Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0224	Pemivibart infusion	Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring
M0239	Bamlanivimab-xxxx infusion	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring
M0240	Casiri and imdev repeat	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
M0241	Casiri and imdev repeat hm	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
M0243	Casirivi and imdevi inj	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
M0244	Casirivi and imdevi inj hm	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0245	Bamlan and etesev infusion	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
M0246	Bamlan and etesev infus home	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency
M0247	Sotrovimab infusion	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
M0248	Sotrovimab inf, home admin	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
M0249	Adm tocilizu covid-19 1st	Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
M0250	Adm tocilizu covid-19 2nd	Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
M0300	Iv chelationtherapy	Iv chelation therapy (chemical endarterectomy)
M0301	Fabric wrapping of aneurysm	Fabric wrapping of abdominal aneurysm
M1000	Pain scr as mod to sevr	Pain screened as moderate to severe
M1001	Pln to adrs pain doc	Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician
M1002	Pln to adrs pain not doc	Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given
M1003	Tb scr 12 mo pri fst bio dz	Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
M1004	Doc med rsn no srn tb	Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)
M1005	Tb scr no perf	Tb screening not performed or results not interpreted, reason not given
M1006	Dz not ases, no rsn	Disease activity not assessed, reason not given
M1007	>=50% total pt outpt ra enct	>=50% of total number of a patient's outpatient ra encounters assessed
M1008	<50% total pt outpt ra encts	<50% of total number of a patient's outpatient ra encounters assessed
M1009	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1010	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1011	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1012	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1013	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1014	Dc epi care doc medrec	Discharge/discontinuation of the episode of care documented in the medical record
M1015	Dc eoc doc med rec	Discharge/discontinuation of the episode of care documented in the medical record
M1016	Pt dx meop or sur steri	Female patients unable to bear children
M1017	Pt admt to palitve serv	Patient admitted to palliative care services
M1018	Pt dx hst cr pt sk lg cr scr	Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients
M1019	Adl pt mj dep ds rs 12 phq<5	Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
M1020	Adl pt mj dep ds no rs 12 mo	Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5
M1021	Pt uc in pp	Patient had only urgent care visits during the performance period
M1022	Pt hospice during perf pd	Patients who were in hospice at any time during the performance period
M1023	Adl pt mj dep ds rs 6 phq<5	Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five
M1024	Adl pt mj dep ds no rs 6 mo	Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five
M1025	Pt hospice during perf pd	Patients who were in hospice at any time during the performance period
M1026	Pt hospice during perf pd	Patients who were in hospice at any time during the performance period
M1027	Img head (ct or mri) obtnd	Imaging of the head (ct or mri) was obtained
M1028	Doc of pt prm hda dx and otr	Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
M1029	Doc sysm rsn img hd	Imaging of the head (ct or mri) was not obtained, reason not given
M1030	Pt clin ind img hd	Patients with clinical indications for imaging of the head
M1031	Pt clin ind img hd	Patients with no clinical indications for imaging of the head
M1032	Adt tkng pharmthry for oud	Adults currently taking pharmacotherapy for oud
M1033	Pharmthry for oud afr 6.30	Pharmacotherapy for oud initiated after june 30th of performance period
M1034	Adt 180 dys pharmthry oud	Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1035	Adt pd out mat pr 180 dys tx	Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
M1036	Adt no 180 dys pharmthry oud	Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1037	Pt dx lum sp reg cacr	Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
M1038	Pt dx lum sp reg fract	Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
M1039	Pt dx lum sp reg inf	Patients with a diagnosis of lumbar spine region infection at the time of the procedure
M1040	Pt dx lum idi or cong scol	Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
M1041	Pt cr ft inf lm or pt id sl	Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1042	Ftl st mea sco ot odi 3 mo	Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
M1043	Fs no odi 9-15mo	Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively
M1044	Ftl st mea odi 3 mo	Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
M1045	Fs oks 9-15mo >= 37 >= 71	Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71
M1046	Fs oks 9-15mo < 37 < 71	Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively
M1047	Fs msrd oks pre and post	Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
M1048	Fsm wth scr odi pre and post	Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively
M1049	Fs wth scr no odi pre and p	Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively
M1050	Fs msrd odi pre and post	Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively
M1051	Pt w/cancer scoliosis	Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1052	Lg pn not meas w/ vas 1yr po	Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively
M1053	Pre and post vas wthn 3 mos	Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively
M1054	Pt uc in pp	Patient had only urgent care visits during the performance period
M1055	Aspirin used	Aspirin or another antiplatelet therapy used
M1056	Presc antico med in pp	Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease
M1057	Aspirin not used, no rsn	Aspirin or another antiplatelet therapy not used, reason not given
M1058	Pt prm nurs hm res in pp	Patient was a permanent nursing home resident at any time during the performance period
M1059	Pt no prm nurs hm res in pp	Patient was in hospice or receiving palliative care at any time during the performance period
M1060	Pt died in pp	Patient died prior to the end of the performance period
M1061	Pt preg	Patient pregnancy
M1062	Pt imcomprmd	Patient immunocompromised
M1063	Pt rec hg dos imsup thpy	Patients receiving high doses of immunosuppressive therapy
M1064	Shing vac doc adm or pv rec	Shingrix vaccine documented as administered or previously received
M1065	Shing vac no adm clinc rsn	Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
M1066	Shing vac no doc no rsn	Shingrix vaccine not documented as administered, reason not given
M1067	Hspc pt prv time meam per	Hospice services for patient provided any time during the measurement period
M1068	Pt not ambulatory	Adults who are not ambulatory
M1069	Pt scr ft fall rsk	Patient screened for future fall risk
M1070	Pt not scrn fut fall no rsn	Patient not screened for future fall risk, reason not given
M1071	Pt had add'l sp pcr perf	Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy
M1106	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1107	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1108	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1109	Oc ni pt dc	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1110	Oc not p pt selfdc	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1111	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1112	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1113	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1114	Oc ni pt dc	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1115	Oc ni pt selfdc	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1116	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1117	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1118	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1119	Oc ni pt dc	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1120	Oc ni pt selfdc	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1121	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1122	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1123	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1124	Oc ni pt dc 1-2 vis	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1125	Oc ni pt selfdc 1-2 vis	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1126	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1127	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1128	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1129	Oc ni pt dc	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1130	Oc ni pt selfdc	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1131	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1132	Oc ni pt home prog	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1133	Oc ni pt dc	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1134	Oc ni pt selfdc	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1135	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1136	Start eoc doc med rec	The start of an episode of care documented in the medical record
M1137	Docu dx degen neuro	Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1138	Oc ni pt 1-2 vis	Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)
M1139	Oc ni pt self dc 1-2 vis	Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1140	Oc ni pt dc 1-2 vis	Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized
M1141	Fs no oks	Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively
M1142	Emerge cases	Emergent cases
M1143	Ni rehab med chiro	Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment
M1144	Oc no ind pt 1-2 vis	Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only
M1145	Mfn drug add-on, per dose	Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)
M1146	Ongoing care not ind	Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1147	Care not poss med rsn	Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1148	Pt self dschg	Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1149	No neck fs prom incap	Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available
M1150	Lvef <=40% or mod/sev l vsf	Left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function
M1151	Pt w/ hx trnsplt or lvad	Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1152	Pt w/ hx trnsplt or lvad	Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1153	Pt w/ dx osteo doe	Patient with diagnosis of osteoporosis on date of encounter
M1154	Hospc serv dur meas pd	Hospice services provided to patient any time during the measurement period
M1155	Pt anphx due to pneum	Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
M1156	Pt recd actv chemo any time	Patient received active chemotherapy any time during the measurement period
M1157	Pt recd bone mar trnsplt	Patient received bone marrow transplant any time during the measurement period
M1158	Pt hx immcomp prior/dur pd	Patient had history of immunocompromising conditions prior to or during the measurement period
M1159	Hospc serv dur meas pd	Hospice services provided to patient any time during the measurement period
M1160	Pt anphx due to mengb bef 13	Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday
M1161	Pt anphx due to dtp bef 13	Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1162	Pt enceph due to dtp bef 13	Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1163	Pt anphx due to hpv bef 13	Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
M1164	Pt w/ dementia any time	Patients with dementia any time during the patient's history through the end of the measurement period
M1165	Pt use hspc dur meas pd	Patients who use hospice services any time during the measurement period
M1166	Path rpt tis spec wle/reexc	Pathology report for tissue specimens produced from wide local excisions or re-excisions
M1167	Hspc dur meas pd	In hospice or using hospice services during the measurement period
M1168	Pt recd flu vax 7/1-6/30	Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1169	Doc med rsn no flu vax	Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
M1170	Pt w/o flu vax 7/1-6/30	Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1171	Pt recd 1 td/tdap 9yrs prior	Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1172	Doc med rsn no td/tdap	Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
M1173	Pt no rec td/tdap 9yrs prior	Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1174	Pt w 2 hzv on/aft 50	Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1175	Doc med rsn no hzv	Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
M1176	Pt w/o hzv on/aft age 50	Patient did not receive at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1177	Pt recd pcv on/aft 60	Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 60th birthday and before the end of the measurement period
M1178	Doc med rsn no pcv	Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)
M1179	No pcv recd	Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 60th birthday and before or during measurement period
M1180	Pt imm ckpt inhib therapy	Patients on immune checkpoint inhibitor therapy
M1181	Gr 2 or> dia or gr2 or> col	Grade 2 or above diarrhea and/or grade 2 or above colitis
M1182	Not elg pre ex ibd/uc/crohn	Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
M1183	Doc imm ckpt inhib hld	Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered
M1184	Doc med rsn no cst/ist rx	Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)
M1185	Imm ckpt inhib not hld no rx	Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
M1186	Pt w/ rx for hspc/plltv care	Patients who have an order for or are receiving hospice or palliative care
M1187	Pt w/ esrd	Patients with a diagnosis of end stage renal disease (esrd)
M1188	Pt w/ ckd stg 5	Patients with a diagnosis of chronic kidney disease (ckd) stage 5
M1189	Doc khe pef w/efgr/uacr	Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
M1190	Doc khe not pef w/efgr/uacr	Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
M1191	Hspc svc any time in meas pd	Hospice services provided to patient any time during the measurement period
M1192	Pt w/ dx sq cell ca of esoph	Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
M1193	Rpts w/ imp/con mmr/msi	Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
M1194	Med rsn no imp/con mmr/msi	Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
M1195	Rpt wo imp/con mmr/msi	Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
M1196	Ixv nrs vrs iqa >=4	Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1197	Isa reduced >=3 fr ixv	Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1198	Isa not red 3pts /no assess	Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1199	Pt rec'g rrt	Patients receiving rrt
M1200	Ace-i/arb rx	Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period
M1201	Med rsn no ace-i/arb rx	Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)
M1202	Pt rsn no ace-i/arb rx	Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)
M1203	No rsn ace-i/arb rx	Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given
M1204	Ixv nrs vrs iqa >=4	Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1205	Isa reduced >=3	Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1206	Isa not red 3pts/no assess	Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1207	Pt scrn sdoh	Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1208	Pt no scrn sdoh	Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1209	>=2 same hi-rsk med w/o diag	At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses
M1210	>=2 same meds tbl4 not ord	At least two orders for high-risk medications from the same drug class, (table 4), not ordered
M1211	Hemoglobin a1c level >9.0%	Most recent hemoglobin a1c level > 9.0%
M1212	Missing hb a1c level	Hemoglobin a1c level is missing, or was not performed during the measurement period (12 months)
M1213	No hx spiro prs spiro>=70%	No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%
M1214	Spiro results wth obs doc	Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed
M1215	Med rsn for no doc spiro	Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)
M1216	No spiro doc no res doc	No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter
M1217	Sys rsn no doc spiro	Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)
M1218	Pt copd symptoms	Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
M1219	Anphx due to vax	Anaphylaxis due to the vaccine on or before the date of the encounter
M1220	Dre wth interp rtnopthy	Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy
M1221	Dre w/o rtnopthy	Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
M1222	Glaucoma pln of care not doc	Glaucoma plan of care not documented, reason not otherwise specified
M1223	Glaucoma plan of care doc	Glaucoma plan of care documented
M1224	Iop dec <20% from base	Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
M1225	Iop dec>=20% from base	Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
M1226	Iop not doc	Iop measurement not documented, reason not otherwise specified
M1227	Eb therapy prescribed	Evidence-based therapy was prescribed
M1228	Pt + hcv aby +vir w/ rx 3 mo	Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
M1229	Pt w/ +hcv +vir ref win 1 mo	Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
M1230	Pt hcv rctv aby no f/u tst	Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
M1231	Pt hcv tst no reactive res	Patient receives hcv antibody test with nonreactive result
M1232	Pt hcv tst reactive result	Patient receives hcv antibody test with reactive result
M1233	Pt no hcv aby or result	Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
M1234	Pt hcv rctv aby f/u neg	Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia
M1235	Doc pt hcv aby rna tst	Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
M1236	Baseline mrs > 2	Baseline mrs > 2
M1237	Pt rsn no scrn	Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)
M1238	Doc 2nd recom hzv 2-6 mo int	Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
M1239	Pt no resp heard	Patient did not respond to the question of patient felt heard and understood by this provider and team
M1240	Pt no resp best int	Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1241	Pt no resp seen as person	Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1242	Pt no resp imprt to me	Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life
M1243	Pt othr thn true heard	Patient provided a response other than completely true for the question of patient felt heard and understood by this provider and team
M1244	Pt othr thn true best int	Patient provided a response other than completely true for the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1245	Pt othr thn true person	Patient provided a response other than completely true for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1246	Pt othr thn true imprt to me	Patient provided a response other than completely true for the question of patient felt this provider and team understood what is important to me in my life
M1247	Pt resp true best int	Patient responded completely true for the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1248	Pt resp true seen as person	Patient responded completely true for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1249	Pt resp true imprt to me	Patient responded completely true for the question of patient felt this provider and team understood what is important to me in my life
M1250	Pt resp true heard	Patient responded as completely true for the question of patient felt heard and understood by this provider and team
M1251	Pts proxy cmplt hu surv	Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement)
M1252	Pts no cmplt hu survey	Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit
M1253	Pts hu surv no amb plltv	Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal)
M1254	Pts deceased prior hu surv	Patients who were deceased when the hu survey reached them
M1255	Pts w/ othr rsn vst,+prg tst	Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)
M1256	Prior history of known cvd	Prior history of known cvd
M1257	Cvd risk assess not perf	Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified
M1258	Cvd risk assess perf	Cvd risk assessment performed, have a documented calculated risk score
M1259	Pt kid transplt wtlst lv don	Patients listed on the kidney-pancreas transplant waitlist or who received a living donor transplant within the first year following initiation of dialysis
M1260	Pt no kd trnsplt wtlst lv do	Patients who were not listed on the kidney-pancreas transplant waitlist or patients who did not receive a living donor transplant within the first year following initiation of dialysis
M1261	Pts on wtlist bef dialysis	Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis
M1262	Pts transplt bef dialysis	Patients who had a transplant prior to initiation of dialysis
M1263	Pts hosp dialysis dt	Patients in hospice on their initiation of dialysis date or during the month of evaluation
M1264	Pts 75+ dialysis dt	Patients age 75 or older on their initiation of dialysis date
M1265	Cms 2728 completed	Cms medical evidence form 2728 for dialysis patients: initial form completed
M1266	Pts admit snf	Patients admitted to a skilled nursing facility (snf)
M1267	Pt no act kid transplt wtlst	Patients not on any kidney or kidney-pancreas transplant waitlist or is not in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1268	Pt ac stat kid trnsplt wtlst	Patients on active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1269	Rec'd esrd mcp lst day of mo	Receiving esrd mcp dialysis services by the provider on the last day of the reporting month
M1270	Pts no kid transplt wtlst	Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1271	Pts dem any time/dur mo	Patients with dementia at any time prior to or during the month
M1272	Pts kid transplt wtlst	Patients on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1273	Pts snf 1 yr dialysis	Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form
M1274	Pts snf exl mo	Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month
M1275	Pts hosp exl	Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period
M1276	Calc bmi out nrm param nof/u	Bmi documented outside normal parameters, no follow-up plan documented, no reason given
M1277	Colorectal ca screen doc rev	Colorectal cancer screening results documented and reviewed
M1278	Pre-htn or htn doc, f/u indc	Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented
M1279	Pre-htn/htn, no f/u, not gvn	Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
M1280	Bilat mast/hx bi /unilat mas	Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
M1281	Bp scrn no perf at interval	Blood pressure reading not documented, reason not given
M1282	Pt scrn tbco id as non user	Patient screened for tobacco use and identified as a tobacco non-user
M1283	Pt scrn tbco and id as user	Patient screened for tobacco use and identified as a tobacco user
M1284	Pt 66+ snp or ltc pos > 90d	Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
M1285	Scrn mam perf rslts not doc	Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
M1286	Bmi doc onl fup not cmpltd	Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason
M1287	Calc bmi blw low param f/u	Bmi is documented below normal parameters and a follow-up plan is documented
M1288	Doc rsn no hbp scrn or f/u	Documented reason for not screening or recommending a follow-up for high blood pressure
M1289	No pt tbco cess interv rng	Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1290	Pt not eli d/t act dig htn	Patient not eligible due to active diagnosis of hypertension
M1291	Pt 66+ frailty and med dem	Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
M1292	Pt 66+ frail inpt adv ill	Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period
M1293	Calc bmi abv up param f/u	Bmi is documented above normal parameters and a follow-up plan is documented
M1294	Bp scrn perf rec interval	Normal blood pressure reading documented, follow-up not required
M1295	Pt hx tot col or colon ca	Patients with a diagnosis or past history of total colectomy or colorectal cancer
M1296	Calc bmi norm parameters	Bmi is documented within normal parameters and no follow-up plan is required
M1297	Bmi not doc medrsn ptref	Bmi not documented due to medical reason or patient refusal of height or weight measurement
M1298	Doc pt preg dur msrmt pd	Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
M1299	Flu immunize order/admin	Influenza immunization administered or previously received
M1300	Flu imm no admin doc rea	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
M1301	Pt recv tbco cess interv	Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1302	Scrn mam perf rslts doc	Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
M1303	Hospc serv dur meas pd	Hospice services provided to patient any time during the measurement period
M1304	No pneum vax admin 19+	Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1305	Pneum vax admin 19+	Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1306	Pt anphx due to pneum	Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
M1307	Doc pt pal or hospice	Documentation stating the patient has received or is currently receiving palliative or hospice care
M1308	Flu immunize no admin	Influenza immunization was not administered, reason not given
M1309	Pall serv during meas	Palliative care services provided to patient any time during the measurement period
M1310	Pt scr tob & cess int	Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user
M1311	Aphlx to vax bef enc	Anaphylaxis due to the vaccine on or before the date of the encounter
M1312	No pt tbco scrn rng	Patient not screened for tobacco use
M1313	No tob scr/cess int	Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
M1314	Bmi not calculated	Bmi not documented and no reason is given
M1315	Crc no doc no rsn	Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified
M1316	Tobacco non-user	Current tobacco non-user
M1317	Pts counsl cpt opt out	Patients who are counseled on connection with a csp and explicitly opt out
M1318	Pts no csp doc contact	Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
M1319	Pts csp doc contact	Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
M1320	Pts scrn + hrsn	Patients who screened positive for at least 1 of the 5 hrsns
M1321	Pts no 7wk inj,no iop,iop>25	Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
M1322	Pts 7wk inj, scrn iop =<25	Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
M1323	Pts 7wk inj, scrn iop >25	Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
M1324	Pts intravitreal/pci	Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
M1325	Doc med rsn not seen	Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
M1326	Pts dx hypotony	Patients with a diagnosis of hypotony
M1327	Pts no eval ini xm no 8 wks	Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
M1328	Pts dx acute vitreous hem	Patients with a diagnosis of acute vitreous hemorrhage
M1329	Pts act pvd 2 wks 8 wks	Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
M1330	Doc pts rsn no f/u xm	Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
M1331	Pts eval ini xm 8 wks	Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
M1332	Pts no eval ini xm no 2 wks	Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
M1333	Acute vitreous hemorrhage	Acute vitreous hemorrhage
M1334	Pts act pvd 2 wks 2 wks	Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
M1335	Doc pts rsn no f/u xm	Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
M1336	Pts eval ini xm 2 wks	Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
M1337	Acute pvd	Acute pvd
M1338	Pt f/u 30-180 dys no + imprv	Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
M1339	Pts f/u 30-180 dys + improv	Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
M1340	Indx whodas 2.0 or sds	Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
M1341	Pt no f/u 30-180 dys	Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period
M1342	Pts died perf per	Patients who died during the performance period
M1343	Pt pam lvl 4 base or srt lin	Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam
M1344	Pts no bsln or 2nd pam score	Patients who did not have a baseline pam score and/or a second score within 6 to 12 month of baseline pam score
M1345	Pt bsln pam, 2nd scr 6-12 mo	Patients who had a baseline pam score and a second score within 6 to 12 month of baseline pam score
M1346	Pts no pam 6 pts 6-12 mo	Patients who did not have a net increase in pam score of at least 6 points within a 6 to 12 month period
M1347	Pt pam incr 3 pt 6-12 mo	Patients who achieved a net increase in pam score of at least 3 points in a 6 to 12 month period (passing)
M1348	Pt pam incr 6 pt 6-12 mo	Patients who achieved a net increase in pam score of at least 6-points in a 6 to 12 month period (excellent)
M1349	Pt no pam 3 pts 6-12 mo	Patients who did not have a net increase in pam score of at least 3 points within 6 to 12 month period
M1350	Pt w/ suic saf pln init rev	Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
M1351	Pt cmplt suicd saf pln 120dy	Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
M1352	Suicd c-ssrs assessment, equ	Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment
M1353	Pts no cmplt suicd saf pln	Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
M1354	Pt no suicd saf pln 120dy	Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
M1355	Suicd based cln eval	Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1356	Pt died dur meas pd	Patients who died during the measurement period
M1357	Pt w/red suic idea 120 days	Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1358	Pts no	Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1359	Indx suicd idea, no 0 scr	Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained
M1360	Suicd c-ssrs assessment	Suicidal ideation and/or behavior symptoms based on the c-ssrs
M1361	Suicd based cln eval	Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1362	Pt died dur meas pd	Patients who died during the measurement period
M1363	Pts no f/u 120 dys	Patients who did not have a follow-up assessment within 120 days of the index assessment
M1364	Ascvd risk >=20pct	Calculated 10-year ascvd risk score of >= 20 percent during the performance period
M1365	Hosp+pall care spec code 17	Patient encounter during the performance period with hospice and palliative care specialty code 17
M1366	Focus on women's health mvp	Focusing on women's health mips value pathway
M1367	Qual care ent disorder mvp	Quality care for the treatment of ear, nose, and throat disorders mips value pathway
M1368	Prev trt inf d/o hiv/hep mvp	Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway
M1369	Qualcare mental hlth/sud mvp	Quality care in mental health and substance use disorders mips value pathway
M1370	Rehab support msk care mvp	Rehabilitative support for musculoskeletal care mips value pathway
M2	Medicare secondary payer	Medicare secondary payer (msp)
MA	Emer med cond susp/confirm	Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition
MB	Auc hardship, insuf internet	Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access
MC	Auc hardship, vendor issues	Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues
MD	Auc hardship, extreme circ	Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances
ME	Order adheres to auc	The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional
MF	Order does not adhere to auc	The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional
MG	Auc not applicable to order	The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional
MH	Auc consult not provided	Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider
MS	6-mo maint/svc fee parts/lbr	Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty